FDA Improving Anaphylaxis Outcomes: Session 3: Current Accessibility to Epinephrine
Автор: The FDA Learning Cache
Загружено: 2025-12-22
Просмотров: 16
Описание:
SUBSCRIBE to @FDALearningCache to see more videos.
Details and supporting materials:
https://fdalearn.com/course/fda-impro...
Public Comment Session:
Individuals who wish to provide remarks during this workshop will have made a request prior to the meeting. This will serve as a listening session for the audience and there will be no moderated discussion.
Moderator:
Brian Canter
Duke-Margolis Institute for Health Policy
Session 3: Current Accessibility to Epinephrine for Treating Anaphylaxis
This session will include discussions on the available data to assess barriers with obtaining, carrying, and using epinephrine. Panelists will consider the institutional barriers presented in community settings and by differing state immunity laws. They will also explore why patients may decide not to use epinephrine during anaphylaxis despite carrying it. There will also be consideration for challenges in accessing care and the need for a prescription to acquire epinephrine.
Moderator:
Michael Pistiner
Massachusetts General Hospital for Children
Panelists:
Kelly Cleary
Food Allergy Research and Education
Ruchi Gupta
Northwestern University
Linda Herbert
Children’s National Hospital
Charity Luiskutty
Food Allergy & Anaphylaxis Connection Team
Christopher Warren
Northwestern University
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
